Antipsychotic Use and Mortality in Persons with Alcohol-Related Dementia or Wernicke-Korsakoff Syndrome: A Nationwide Register Study in Finland
- PMID: 37445298
- PMCID: PMC10342345
- DOI: 10.3390/jcm12134263
Antipsychotic Use and Mortality in Persons with Alcohol-Related Dementia or Wernicke-Korsakoff Syndrome: A Nationwide Register Study in Finland
Abstract
Background: Research on the use of psychotropic drugs in people with alcohol-related neurocognitive disorders is virtually nonexistent. We examined the prevalence of antipsychotic drug use and its effect on mortality among patients with Wernicke-Korsakoff syndrome (WKS) or alcohol-related dementia (ARD).
Methods: In this nationwide register study, we collected data on the medication use and mortality of all persons aged ≥40 diagnosed with WKS (n = 1149) or ARD (n = 2432) between 1998 and 2015 in Finland. We calculated the prevalence of antipsychotic use within one year of diagnosis and the adjusted cumulative mortality of antipsychotic users versus non-users in relation to the age-, sex-, and calendar year-matched general population.
Results: Of the WKS and ARD patients, 35.9% and 38.5%, respectively, purchased one or more antipsychotic drugs in the year following diagnosis. The adjusted cumulative mortality of the antipsychotic users was significantly lower than that of non-users in both the WKS and ARD groups, where the adjusted hazard ratios (95% CI) were 0.85 (0.72-0.99) and 0.73 (0.65-0.81), respectively. WKS and ARD patients using antipsychotics were less likely to die of alcohol-related causes than antipsychotic non-users, but the difference was significant only in the ARD group.
Conclusions: This population-based study shows that antipsychotic use is common in patients with WKS or ARD. In contrast to other dementia studies, our results indicate that the mortality of antipsychotic users is significantly lower than that of non-users. The lower mortality could be explained by decreased alcohol use and better healthcare coverage in antipsychotic users.
Keywords: Wernicke–Korsakoff syndrome; alcohol-related dementia; antipsychotics; mortality.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Incidence and mortality of alcohol-related dementia and Wernicke-Korsakoff syndrome: A nationwide register study.Int J Geriatr Psychiatry. 2022 Aug;37(8):10.1002/gps.5775. doi: 10.1002/gps.5775. Int J Geriatr Psychiatry. 2022. PMID: 35789035 Free PMC article.
-
Criminal behavior in alcohol-related dementia and Wernicke-Korsakoff syndrome: a Nationwide Register Study.Eur Arch Psychiatry Clin Neurosci. 2024 Apr 13. doi: 10.1007/s00406-024-01804-0. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2024. PMID: 38613687
-
Prevalence and Improvement of Caine-Positive Wernicke-Korsakoff Syndrome in Psychiatric Inpatient Admissions.Psychosomatics. 2020 Jan-Feb;61(1):31-38. doi: 10.1016/j.psym.2019.08.002. Epub 2019 Aug 14. Psychosomatics. 2020. PMID: 31607504
-
Wernicke-Korsakoff syndrome not related to alcohol use: a systematic review.J Neurol Neurosurg Psychiatry. 2015 Dec;86(12):1362-8. doi: 10.1136/jnnp-2014-309598. Epub 2015 Jan 14. J Neurol Neurosurg Psychiatry. 2015. PMID: 25589780 Review.
-
Alcohol-related dementia: an update of the evidence.Alzheimers Res Ther. 2013 Jan 25;5(1):3. doi: 10.1186/alzrt157. eCollection 2013. Alzheimers Res Ther. 2013. PMID: 23347747 Free PMC article. Review.
References
-
- Edahiro A., Miyamae F., Taga T., Sugiyama M., Kikuchi K., Okamura T., Awata S. Incidence and Distribution of Subtypes of Early-onset Dementia in Japan: A Nationwide Analysis Based on Annual Performance Reports of the Medical Centers for Dementia. Geriatr. Gerontol. Int. 2020;20:1050–1055. doi: 10.1111/ggi.14043. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources